The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Nanoparticles in Clinical Translation for Cancer Therapy
Open accessAbstract
The advent of cancer therapeutics brought a paradigm shift from conventional therapy to precision medicine. The new therapeutic modalities accomplished through the properties of nanomaterials have extended their scope in cancer therapy beyond conventional drug delivery. Nanoparticles can be channeled in cancer therapy to encapsulate active pharmaceutical ingredients and deliver them to the tumor site in a more efficient manner. This review enumerates various types of nanoparticles that have entered clinical trials for cancer treatment. The obstacles in the journey of nanodrug from clinic to market are reviewed. Furthermore, the latest developments in using nanoparticles in cancer therapy are also highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
Wang, H., Gao, Z., Liu, X., Agarwal, P., Zhao, S., Conroy, D. W., Ji, G., Yu, J., Jaroniec, C. P., Liu, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02915-8 · Cited by 331
RetractedPrinciples of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846 · cited 1×
“heterogeneity among cancers, which in turn, drives chemoresistance [8].”
BackgroundControlled drug delivery vehicles for cancer treatment and their performance
Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164 · cited 1×
“placed them in a good position in cancer therapy, especially in ovarian, breast, and non-small cell lung cancers [3].”
BackgroundCytokines in clinical cancer immunotherapy
Berraondo, P., Sanmamed, M. F., Ochoa, M. C., Etxeberria, I., Aznar, M. A., Pérez-Gracia, J. L., Rodríguez-Ruiz, M. E., Ponz-Sarvise, M., Castañón, E., & Melero, I. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0328-y · Cited by 1,205
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069 · cited 1×
“The long process of drug development [114] Years required for pre-clinical and clinical research on higher animals and humans [115] Hassles in obtaining regulatory approval to release the drug in the market [116] Failure to effectively load the drug inside the nanoparticles [117] Instability of the formulation [118] I…”
BackgroundMinimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Metal complexes in cancer therapy – an update from drug design perspective
Ndagi, U., Mhlongo, N., & Soliman, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s119488 · Cited by 935
Duan, X., & Li, Y. (2013) · Small · doi:10.1002/smll.201201390 · Cited by 926
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
Gold Nanoparticles for Photothermal Cancer Therapy
Vines, J. B., Yoon, J.-H., Ryu, N.-E., Lim, D.-J., & Park, H. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00167 · Cited by 906
Finn, J. D., Smith, A. R., Patel, M. C., Shaw, L., Youniss, M. R., van Heteren, J., Dirstine, T., Ciullo, C., Lescarbeau, R., Seitzer, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.014 · Cited by 878
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
DiMasi, J. A., Feldman, L., Seckler, A., & Wilson, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.295 · Cited by 845
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
Ventola, C. L. (2017) · Europe PMC (PubMed Central) · Cited by 835
BRD4 and Cancer: going beyond transcriptional regulation
Donati, B., Lorenzini, E., & Ciarrocchi, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0915-9 · Cited by 708
Nanopharmaceuticals and Nanomedicines Currently on the Market: Challenges and Opportunities
Farjadian, F., Ghasemi, A., Gohari, O., Roointan, A., Karimi, M., & Hamblin, M. R. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0120 · Cited by 664
Current hurdles to the translation of nanomedicines from bench to the clinic
Đorđević, S., Gonzalez, M. M., Conejos-Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi-Fainaro, R., Florindo, H. F., & Vicent, M. J. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01024-2 · Cited by 657
Liposomal Drug Delivery Systems and Anticancer Drugs
Olusanya, T., Haj Ahmad, R., Ibegbu, D., Smith, J., & Elkordy, A. (2018) · Molecules · doi:10.3390/molecules23040907 · Cited by 603
Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures
He, H., Liu, L., Morin, E. E., Liu, M., & Schwendeman, A. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00228 · Cited by 588
The role of HER2 in cancer therapy and targeted drug delivery
Tai, W., Mahato, R., & Cheng, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.009 · Cited by 555
Polymeric micelles in cancer therapy: State of the art
Ghosh, B., & Biswas, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.016 · Cited by 546
Targeted therapy using nanotechnology: focus on cancer
Sechi, M., Sanna, V., & Pala, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s36654 · Cited by 493
Multifunctional biomolecule nanostructures for cancer therapy
Wang, J., Li, Y., & Nie, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00315-x · Cited by 488
Cellular Uptake of Nanoparticles versus Small Molecules: A Matter of Size
Mosquera, J., García, I., & Liz-Marzán, L. M. (2018) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00292 · Cited by 487
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.002 · Cited by 425
Stimuli-responsive polymeric micelles for drug delivery and cancer therapy
Zhou, Q., Zhang, L., Yang, T., & Wu, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s158696 · Cited by 408
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
Duan, L., Ouyang, K., Xu, X., Xu, L., Wen, C., Zhou, X., Qin, Z., Xu, Z., Sun, W., & Liang, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.673286 · Cited by 377
Oncolytic viruses for cancer immunotherapy
Hemminki, O., dos Santos, J. M., & Hemminki, A. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00922-1 · Cited by 351
Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
Marques, A. C., Costa, P. J., Velho, S., & Amaral, M. H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.035 · Cited by 349
PROTAC Technology: Opportunities and Challenges
Gao, H., Sun, X., & Rao, Y. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00597 · Cited by 345
Liu, Y., Blanchfield, L., Ma, V. P.-Y., Andargachew, R., Galior, K., Liu, Z., Evavold, B., & Salaita, K. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600163113 · Cited by 329
Clinical development of new drug–radiotherapy combinations
on behalf of the NCRI CTRad Academia-Pharma Joint Working Group, Sharma, R. A., Plummer, R., Stock, J. K., Greenhalgh, T. A., Ataman, O., Kelly, S., Clay, R., Adams, R. A., Baird, R. D., et al. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.79 · Cited by 320
Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles
Cheow, W. S., & Hadinoto, K. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.033 · Cited by 297
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113891 · Cited by 289
Setyawati, M. I., Tay, C. Y., Bay, B. H., & Leong, D. T. (2017) · ACS Nano · doi:10.1021/acsnano.7b01744 · Cited by 282
Relating Cytotoxicity, Zinc Ions, and Reactive Oxygen in ZnO Nanoparticle–Exposed Human Immune Cells
Shen, C., James, S. A., de Jonge, M. D., Turney, T. W., Wright, P. F. A., & Feltis, B. N. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft187 · Cited by 272
Al-Sheddi, E. S., Farshori, N. N., Al-Oqail, M. M., Al-Massarani, S. M., Saquib, Q., Wahab, R., Musarrat, J., Al-Khedhairy, A. A., & Siddiqui, M. A. (2018) · Bioinorganic Chemistry and Applications · doi:10.1155/2018/9390784 · Cited by 270
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
Rommasi, F., & Esfandiari, N. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03553-8 · Cited by 269
Application of magnetic nanoparticles in nucleic acid detection
Tang, C., He, Z., Liu, H., Xu, Y., Huang, H., Yang, G., Xiao, Z., Li, S., Liu, H., Deng, Y., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00613-6 · Cited by 262
Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities
Agrahari, V., & Agrahari, V. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.047 · Cited by 253
Deng, J., Xu, S., Hu, W., Xun, X., Zheng, L., & Su, M. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.048 · Cited by 234 · cited 1×
“Bismuth lipophilic nanoparticles effectively enhanced the X-ray radiation therapy against breast cancer cells [44], thus effectively inducing a concentration-dependent cell growth inhibition in breast cancer cell lines by possibly altering the membrane permeability and damaging the genomic DNA [45].”
BackgroundHyperthermia using nanoparticles – Promises and pitfalls
Kaur, P., Aliru, M. L., Chadha, A. S., Asea, A., & Krishnan, S. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1120889 · Cited by 228
New opportunities for nanoparticles in cancer immunotherapy
Park, W., Heo, Y.-J., & Han, D. K. (2018) · Biomaterials Research · doi:10.1186/s40824-018-0133-y · Cited by 216
Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review
He, Z., Zhang, Y., & Feng, N. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.110298 · Cited by 215
Hou, S., Zhao, L., Shen, Q., Yu, J., Ng, C., Kong, X., Wu, D., Song, M., Shi, X., Xu, X., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208452 · Cited by 211
Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation
Buttacavoli, M., Albanese, N. N., Di Cara, G., Alduina, R., Faleri, C., Gallo, M., Pizzolanti, G., Gallo, G., Feo, S., Baldi, F., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.23859 · Cited by 206
Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
Salvioni, L., Rizzuto, M. A., Bertolini, J. A., Pandolfi, L., Colombo, M., & Prosperi, D. (2019) · Cancers · doi:10.3390/cancers11121855 · Cited by 201
Miao, Z., Jiang, S., Ding, M., Sun, S., Ma, Y., Younis, M. R., He, G., Wang, J., Lin, J., Cao, Z., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05035 · Cited by 197
Liu, Q., Zhao, K., Wang, C., Zhang, Z., Zheng, C., Zhao, Y., Zheng, Y., Liu, C., An, Y., Shi, L., et al. (2019) · Advanced Science · doi:10.1002/advs.201801423 · Cited by 190
Ferrari, R., Sponchioni, M., Morbidelli, M., & Moscatelli, D. (2018) · Nanoscale · doi:10.1039/c8nr05933k · Cited by 189
Ahamed, M., Khan, M. A. M., Akhtar, M. J., Alhadlaq, H. A., & Alshamsan, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17559-9 · Cited by 185
Pillay, V., Murugan, K., Choonara, Y. E., Kumar, P., Bijukumar, D., & du Toit, L. C. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s75615 · Cited by 175
Application of nanotechnology to cancer radiotherapy
Mi, Y., Shao, Z., Vang, J., Kaidar‐Person, O., & Wang, A. Z. (2016) · Cancer Nanotechnology · doi:10.1186/s12645-016-0024-7 · Cited by 174
Synthetic and living micropropellers for convection-enhanced nanoparticle transport
Schuerle, S., Soleimany, A. P., Yeh, T., Anand, G. M., Häberli, M., Fleming, H. E., Mirkhani, N., Qiu, F., Hauert, S., Wang, X., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav4803 · Cited by 154
Liposome and Their Applications in Cancer Therapy
Pandey, H., Rani, R., & Agarwal, V. K. (2016) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2016150477 · Cited by 151
Hassan, H. A. F. M., Smyth, L. A., Wang, J. T.-W., Costa, P. M., Ratnasothy, K., Diebold, S. S., Lombardi, G., & Al‐Jamal, K. T. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.005 · Cited by 150
Nanoparticle Density: A Critical Biophysical Regulator of Endothelial Permeability
Tay, C. Y., Setyawati, M. I., & Leong, D. T. (2017) · ACS Nano · doi:10.1021/acsnano.6b07806 · Cited by 149
Recent advances in drug delivery systems for enhancing drug penetration into tumors
He, B., Sui, X., Yu, B., Wang, S., Shen, Y., & Cong, H. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1831106 · Cited by 146
Wu, F., Zhu, J., Li, G., Wang, J., Veeraraghavan, V. P., Surapaneni, K. M., & Zhang, Q. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1647224 · Cited by 144
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
Maria, R. D., Sante, G. D., Piro, G., Carbone, C., Tortora, G., Boldrini, L., Pietragalla, A., Daniele, G., Tredicine, M., Cesario, A., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030216 · Cited by 143
Fluorescent sensors using DNA-functionalized graphene oxide
Liu, Z., Liu, B., Ding, J., & Liu, J. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7888-3 · Cited by 142
Targeting Endothelial Cell Junctions with Negatively Charged Gold Nanoparticles
Wang, J., Zhang, L., Peng, F., Shi, X., & Leong, D. T. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b00840 · Cited by 134
Mechanisms of the Cytotoxic Effect of Selenium Nanoparticles in Different Human Cancer Cell Lines
Varlamova, E. G., Goltyaev, M. V., Mal’tseva, V. N., Turovsky, E. A., Sarimov, R. M., Simakin, A. V., & Gudkov, S. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157798 · Cited by 134
Targeted Radionuclide Therapy: A Historical and Personal Review
Goldsmith, S. J. (2019) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2019.07.006 · Cited by 132
Gul, A. R., Shaheen, F., Rafique, R., Bal, J., Waseem, S., & Park, T. J. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127202 · Cited by 132
Nanomedicine in treatment of breast cancer – A challenge to conventional therapy
Afzal, M., Zafar, A., Alharbi, K. S., Alruwaili, N. K., Al-Abbasi, F. A., Almalki, A. A., Kazmi, I. A., Kumar, V., Kamal, M. A., Nadeem, M. S., et al. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.016 · Cited by 130
Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications
Guan, B., & Zhang, X. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s237544 · Cited by 125
An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy
Bu, J., Nair, A., Iida, M., Jeong, W., Poellmann, M. J., Mudd, K., Kubiatowicz, L. J., Liu, E. W., Wheeler, D. L., & Hong, S. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00953 · Cited by 121
Multiplex cancer cell detection by SERS nanotags with cyanine and triphenylmethine Raman reporters
Maiti, K. K., Samanta, A., Vendrell, M., Soh, K.-S., Olivo, M., & Chang, Y. (2011) · Chemical Communications · doi:10.1039/c0cc05265e · Cited by 119
A review on hyperthermia via nanoparticle-mediated therapy
Sohail, A., Ahmad, Z., Bég, O. A., Arshad, S., & Sherin, L. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.02.003 · Cited by 119
Guo, P., Yang, J., Huang, J., Auguste, D. T., & Moses, M. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904697116 · Cited by 118
Gargett, T., Abbas, M. N., Rolan, P. E., Price, J. D., Gosling, K. M., Ferrante, A., Ruszkiewicz, A. R., Atmosukarto, I. I., Altin, J. G., Parish, C. R., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2207-z · Cited by 116
DNA Nanotechnology for Cancer Diagnosis and Therapy
Chen, T., Ren, L., Liu, X., Zhou, M., Li, L., Xu, J., & Zhu, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061671 · Cited by 113
Saraswat, A. L., Patki, M., Fu, Y., Barot, S., Dukhande, V. V., & Patel, K. R. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0156 · Cited by 110
CRLX101 (formerly IT-101) – A Novel Nanopharmaceutical of Camptothecin in Clinical Development
Young, C., Schluep, T., Hwang, J., & Eliasof, S. D. (2011) · Current Bioactive Compounds · doi:10.2174/157340711795163866 · Cited by 108
Challenges towards Targeted Drug Delivery in Cancer Nanomedicines
Hafeez, M. N., Celia, C., & Petrikaitė, V. (2021) · Processes · doi:10.3390/pr9091527 · Cited by 106
Schneider‐Futschik, E. K., & Reyes‐Ortega, F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081157 · Cited by 100
Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
Varlamova, E. G., Turovsky, E. A., & Блинова, Е. В. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910808 · Cited by 99
Huang, W., Lin, J.-N., Hsieh, J., Chou, S., Lai, C., Yun, E.-J., Lo, U., Pong, R.-C., Lin, Y.-H., & Lin, Y.-H. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b10029 · Cited by 97
Das, M., Shen, L., Liu, Q., Goodwin, T. J., & Huang, L. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.11.012 · Cited by 97
Ma, Y., Zhu, Y., Tang, X., Hang, L., Jiang, W., Li, M., Khan, M. I., You, Y., & Wang, Y. (2019) · Biomaterials Science · doi:10.1039/c9bm00333a · Cited by 97
Shi, J., Yang, X., Li, Y., Wang, D., Liu, W., Zhang, Z., Liu, J., & Zhang, K. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120221 · Cited by 97
Targeted magnetic nanoparticle hyperthermia for the treatment of oral cancer
Legge, C. J., Colley, H. E., Lawson, M. A., & Rawlings, A. E. (2019) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12921 · Cited by 96
Nanoscale artificial antigen presenting cells for cancer immunotherapy
Rhodes, K. R., & Green, J. J. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.02.016 · Cited by 95
Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy
Thakur, N., Thakur, S., Chatterjee, S., Das, J., & Sil, P. C. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.597806 · Cited by 92
Combination Strategies to Improve Targeted Radionuclide Therapy
Chan, T. G., O’Neill, E., Habjan, C., & Cornelissen, B. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.248062 · Cited by 91 · cited 1×
“The development of drug mimetics where a drug-like molecule can thwart the cancer-inducing effects of mutated regulator proteins [153,154], targeted radionuclide therapy (TRNT) where the radionuclides can potentially destroy tumor cells even if they do not possess specific tumor-associated antigen or receptor or bioma…”
BackgroundDrug safety: The concept, inception and its importance in patients’ health
Alshammari, T. M. (2014) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2014.04.008 · Cited by 90
Ge, H., Wang, D., Pan, Y., Guo, Y., Li, H., Zhang, F., Zhu, X., Li, Y., Zhang, C., & Huang, L. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202000831 · Cited by 90
Cimas, F. J., Niza, E., Juan, A., Noblejas‐López, M. D. M., Bravo, I., Lara‐Sánchez, A., Alonso‐Moreno, C., & Ocaña, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100986 · Cited by 90
Yeh, M., Chen, C.-C., Hsieh, D.-S., Huang, K., Chan, Y.-L., Hong, P., & Wu, C. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s58414 · Cited by 89
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET
Simonetta, F., Alam, I. S., Lohmeyer, J. K., Sahaf, B., Good, Z., Chen, W., Xiao, Z., Hirai, T., Scheller, L., Engels, P., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2770 · Cited by 89
Using gold nanoparticles in diagnosis and treatment of melanoma cancer
Bagheri, S., Yasemi, M., Qamsari, E. S., Rashidiani, J., Abkar, M., Hassani, M., Mirhosseini, S. A., & Kooshki, H. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1430585 · Cited by 87
Das, S., Roy, A., Barui, A. K., Alabbasi, M. M. A., Kuncha, M., Sistla, R., Sreedhar, B., & Patra, C. R. (2020) · Nanoscale · doi:10.1039/d0nr00631a · Cited by 86
Wang, Y., Han, L., Liu, F., Yang, F., Jiang, X., Sun, H., Feng, F., Xue, J., & Liu, W. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110795 · Cited by 84
Clearable Black Phosphorus Nanoconjugate for Targeted Cancer Phototheranostics
Jana, D., Jia, S., Bindra, A. K., Xing, P., Ding, D., & Zhao, Y. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c02718 · Cited by 82
Radiosensitization Effect of Gold Nanoparticles in Proton Therapy
Cunningham, C., de Kock, M., Engelbrecht, M., Miles, X., Slabbert, J. P., & Vandevoorde, C. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.699822 · Cited by 79
Platinum nanoparticles induce damage to DNA and inhibit DNA replication
Nejdl, L., Kudr, J., Moulick, A., Hegerova, D., Ruttkay-Nedecký, B., Gumulec, J., Číhalová, K., Šmerková, K., Dostálová, S., Křížková, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180798 · Cited by 78
Bao, W., Tian, F., Lyu, C., Liu, B., Li, B., Zhang, L., Liu, X., Li, F., Li, D., Gao, X., et al. (2021) · Science Advances · doi:10.1126/sciadv.aba2458 · Cited by 75
Bisht, G., Rayamajhi, S., Biplab, K. C., Paudel, S. N., Karna, D., & Shrestha, B. G. (2016) · Nanoscale Research Letters · doi:10.1186/s11671-016-1734-9 · Cited by 74
Guryev, E. L., Volodina, N. O., Shilyagina, N. Y., Gudkov, S. V., Balalaeva, I. V., Volovetsky, A. B., Lyubeshkin, A. V., Sen’, A. V., Ermilov, S. A., Vodeneev, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809258115 · Cited by 71
Druck, T., Cheung, D. G., Park, D., Trapasso, F., Pichiorri, F., Gaspari, M., Palumbo, T., Aqeilan, R. I., Gaudio, E., Okumura, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1414-7 · Cited by 66
Protein Catenation Enhances Both the Stability and Activity of Folded Structural Domains
Wang, X., & Zhang, W. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201705194 · Cited by 65
Zhang, T., Li, Y., Hong, W., Chen, Z., Peng, P., Yuan, S., Qu, J., Xiao, M., & Xu, L. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb03320j · Cited by 65
Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine
Huai, Y., Zhang, Y., Xiong, X., Das, S., Bhattacharya, R., & Mukherjee, P. (2019) · Cell Stress · doi:10.15698/cst2019.08.195 · Cited by 65
Khan, S., Ansari, A. A., Khan, A. A., Abdulla, M., Al-Obaid, O. A., & Ahmad, R. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.03.005 · Cited by 63
Peroxidase‐Like Nanozymes Induce a Novel Form of Cell Death and Inhibit Tumor Growth In Vivo
Wang, P., Liu, S., Hu, M., Zhang, H., Duan, D., He, J., Hong, J., Lv, R., Choi, H. S., Yan, X., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000647 · Cited by 63
Shao, J., Liang, R., Ding, D., Zheng, X., Zhu, X., Hu, S., Wei, H., & Wei, B. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s289310 · Cited by 61
Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery
Wang, S., Zhang, F., Yu, G., Wang, Z., Jacobson, O., Ma, Y., Tian, R., Deng, H., Yang, W., Chen, Z., et al. (2020) · Theranostics · doi:10.7150/thno.47849 · Cited by 60
Tecemotide: An antigen-specific cancer immunotherapy
Wurz, G. T., Kao, C.-J., Wolf, M., & DeGregorio, M. W. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29836 · Cited by 59
Das, K., Belnoue, E., Rossi, M., Hofer, T., Danklmaier, S., Nolden, T., Schreiber, L.-M., Angerer, K., Kimpel, J., Hoegler, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25506-6 · Cited by 59
The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
Matias, M., Pinho, J. O., Penetra, M. J., Campos, G., Reis, C. P., & Gaspar, M. M. (2021) · Cells · doi:10.3390/cells10113088 · Cited by 57
The Emerging Potential of Multi-Ion Radiotherapy
Ebner, D. K., Frank, S. J., Inaniwa, T., Yamada, S., & Shirai, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.624786 · Cited by 56
Payne, M., Ellis, P., Dunlop, D. J., Ranson, M., Danson, S. J., Schacter, L., & Talbot, D. C. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31631-2 · Cited by 55
Stimuli‐Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy
Lorkowski, M. E., Atukorale, P. U., Ghaghada, K. B., & Karathanasis, E. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001044 · Cited by 52
Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
Zhao, X.-Y., Wang, X., Wei, Q.-Y., Xu, Y., & Lau, A. T. Y. (2020) · Cells · doi:10.3390/cells9041012 · Cited by 50
Lakshmi, B. A., Ankireddy, S. R., Sangubotla, R., Hong, J. W., & Kim, S. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111773 · Cited by 50
Turovsky, E. A., & Varlamova, E. G. (2021) · Biology · doi:10.3390/biology10080743 · Cited by 50
Hernández-Delgadillo, R., García-Cuellar, C. M., Sánchez-Pérez, Y., Pineda‐Aguilar, N., Martínez-Martínez, M. A., Padilla, E. E. R., Nakagoshi-Cepeda, S. E., Solís-Soto, J. M., Sánchez-Najéra, R. I., Nakagoshi-Cepeda, M. A. A., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s179095 · Cited by 49
Fujiwara, R., Luo, Y., Sasaki, T., Fujii, K., Ohmori, H., & Kuniyasu, H. (2015) · Pathobiology · doi:10.1159/000439404 · Cited by 46
Peukert, D., Kempson, I. M., Douglass, M. J. J., & Bezak, E. (2019) · Medical Physics · doi:10.1002/mp.13923 · Cited by 46
Wu, W., Bai, X., Shao, Y., Yang, C., Wei, J., Wei, W., & Zhang, W. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c06169 · Cited by 46
Akbarzadeh-Khiavi, M., Safary, A., Barar, J., Farzi-Khajeh, H., Barzegari, A., Mousavi, R., Somi, M. H., & Omidi, Y. (2019) · Bioimpacts · doi:10.15171/bi.2020.04 · Cited by 45
Mout, R., & Rotello, V. M. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2586 · Cited by 44
Ishikawa, T., Kageyama, S., Miyahara, Y., Okayama, T., Kokura, S., Wang, L., Sato, E., Yagita∥, H., Itoh, Y., & Shiku, H. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02892-w · Cited by 44
Peukert, D., Kempson, I. M., Douglass, M. J. J., & Bezak, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174280 · Cited by 42
Weng, X., Huang, X., Li, H., Lin, S., Rao, X., Guo, X., & Huang, P. (2020) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000671 · Cited by 41
Mignani, S. M., Shi, X., Ceña, V., Rodrigues, J., Tomás, H., & Majoral, J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.003 · Cited by 40
Yardley, D. A., Brufsky, A., Coleman, R. E., Conte, P., Cortés, J., Glück, S., Nabholtz, J., O’Shaughnessy, J., Beck, R. M., Ko, A., et al. (2015) · Trials · doi:10.1186/s13063-015-1101-7 · Cited by 39
Jiang, T., Zhang, B., Zhang, L. J., Wu, X., Li, H., Shen, S., Luo, Z., Liu, X., Hu, Y., Pang, Z., et al. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1445093 · Cited by 39
Current and Future Advancements of Raman Spectroscopy Techniques in Cancer Nanomedicine
Canetta, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313141 · Cited by 39
Zhao, X., Takabayashi, F., & Ibuki, Y. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.06.046 · Cited by 38
Rivera‐Rodriguez, A., Chiu‐Lam, A., Morozov, V. M., Ishov, A. M., & Rinaldi, C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s171130 · Cited by 36
Targeted delivery, drug release strategies, and toxicity study of polymeric drug nanocarriers
Abasian, P., Shakibi, S., Maniati, M. S., Khorasani, S. N., & Khalili, S. (2020) · Polymers for Advanced Technologies · doi:10.1002/pat.5168 · Cited by 35
Song, S., Jin, X., Zhang, L., Zhao, C., Ding, Y., Ang, Q.-Q., Khaidav, O., & Shen, C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s195828 · Cited by 34
Bakshi, S. F., Zakharchenko, A., Minko, S., Kolpashchikov, D. M., & Katz, E. (2019) · Magnetochemistry · doi:10.3390/magnetochemistry5020024 · Cited by 33
Receptor-mediated delivery of therapeutic RNA by peptide functionalized curdlan nanoparticles
Ganbold, T., Han, S., Hasi, A., & Baigude, H. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.12.152 · Cited by 31
Krishnan, T., Wang, H., & Vo‐Dinh, T. (2021) · Sensors · doi:10.3390/s21238044 · Cited by 30
Winter, H., Brown, A. L., & Goforth, A. M. (2018) · InTech eBooks · doi:10.5772/intechopen.76413 · Cited by 28
Peroxiredoxin 6 Down-Regulation Induces Metabolic Remodeling and Cell Cycle Arrest in HepG2 Cells
López-Grueso, M. J., Valero, R. M., Carmona‐Hidalgo, B., Ruiz, D., Peinado, J., McDonagh, B., Requejo-Aguilar, R., Ruiz, J. A., & Padilla, C. A. (2019) · Antioxidants · doi:10.3390/antiox8110505 · Cited by 28
Hou, S., Zhao, L., Shen, Q., Yu, J., Ng, C., Kong, X., Wu, D., Song, M., Shi, X., Xu, X., et al. (2013) · Angewandte Chemie · doi:10.1002/ange.201208452 · Cited by 27
Jia, X., Guo, M., Han, Q., Tian, Y., Yuan, Y., Wang, Z., Qian, Y., & Wang, W. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00440 · Cited by 25
Tiboni, M., Coppari, S., Casettari, L., Guescini, M., Colomba, M., Fraternale, D., Gorassini, A., Verardo, G., Ramakrishna, S., Guidi, L., et al. (2020) · Nanomaterials · doi:10.3390/nano11010036 · Cited by 25
Bhowmik, T., & Gomes, A. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.03.009 · Cited by 24
Jan, Y. J., Yoon, J., Chen, J., Teng, P., Yao, N., Cheng, S. H., Lozano, A., Chu, G. C., Chung, H., Lu, Y.-T., et al. (2019) · Theranostics · doi:10.7150/thno.34485 · Cited by 24
Sweeney, E. E., Balakrishnan, P. B., Powell, A. B., Bowen, A., Sarabia, I., Burga, R. A., Jones, R. B., Bosque, A., Cruz, C. C., & Fernandes, R. (2020) · Nano Research · doi:10.1007/s12274-020-2684-1 · Cited by 23
Baig, M. M. F. A., Lai, W., Akhtar, M. F., Saleem, A., Ahmed, S. A., & Xia, X. (2020) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2020.100523 · Cited by 22
Du, Y., Wang, S., Zhang, T., He, D., Tu, J., & Shen, Y. (2020) · Drug Delivery · doi:10.1080/10717544.2019.1709919 · Cited by 21
Defining the susceptibility of colorectal cancers to BH3-mimetic compounds
Luo, M., Palmieri, M., Riffkin, C. D., Sakthianandeswaren, A., Djajawi, T. M., Hirokawa, Y., Shuttleworth, V. G., Segal, D., White, C. A., Nhu, D., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02815-0 · Cited by 18
Protein Catenation Enhances Both the Stability and Activity of Folded Structural Domains
Wang, X., & Zhang, W. (2017) · Angewandte Chemie · doi:10.1002/ange.201705194 · Cited by 16
Fe3O4 Nanopowders: Genomic and Apoptotic Evaluations on A549 Lung Adenocarcinoma Cell Line
Kaplan, A., Kutlu, H. M., & Çiftçi, G. A. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1643031 · Cited by 14
Goswitz, V. C., & Sawicki, Z. (2012) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221413804660926 · Cited by 10
Tourneau, C. L., Calugaru, V., Jouffroy, T., Rodriguez, J., Hoffmann, C., Dodger, B., Moreno, V., & Calvo, E. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.6080 · Cited by 6
Cited by
Biosynthesis of Gold and Silver Nanoparticles Using Phytochemical Compounds
Zuhrotun, A., Oktaviani, D. J., & Hasanah, A. N. (2023) · Molecules · doi:10.3390/molecules28073240 · Cited by 281
Roshani, M., Rezaian-Isfahni, A., Lotfalizadeh, M. H., Khassafi, N., Abadi, M. H. J. N., & Nejati, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03115-1 · Cited by 84
Thirumoorthy, G., Balasubramanian, B., George, J. A., Nizam, A., Nagella, P., Srinatha, N., Pappuswamy, M., Alanazi, A. M., Meyyazhagan, A., Rengasamy, K. R. R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-51647-x · Cited by 79
Recent advances in targeted drug delivery systems for resistant colorectal cancer
Sharifi-Azad, M., Fathi, M., Cho, W. C., Barzegari, A., Dadashi, H., Dadashpour, M., & Jahanban-Esfahlan, R. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02605-y · Cited by 65
Self-citation
Metadata
- Authors
- Mundekkad, D., & Cho, W. C.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-02-01
- Volume
- 23
- Issue
- 3
- Pages
- 1685
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4210534116
- Cited by
- 305
- References
- 154
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.